Symptomatology, pathophysiology and treatment perspectives of "long COVID" syndrome
The year 2020 was marked in history by the pandemic of SARS-CoV-2 infection. The relatively quick introduction of vaccinations and antiviral drugs (e.g. orally administered molnupiravir, nirmatrelvir/ritonavir) allowed the global nature of COVID-19 to be controlled after more than 2 years. Currently...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Kniha |
| Vydáno: |
Polish Pharmaceutical Society,
2024-04-01T00:00:00Z.
|
| Témata: | |
| On-line přístup: | Connect to this object online. |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Jednotka 1 | Dostupné |